Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

RUFY4 Activators

RUFY4 Activators encompass a distinct category of chemical compounds that facilitate the functional activity of the Run and FYVE domain-containing protein 4 (RUFY4) through the modulation of specific intracellular signaling cascades. These activators work by targeting cellular mechanisms and pathways that are integral to the functional expression and activity of RUFY4, a protein that plays a pivotal role in processes such as vesicular trafficking and autophagy. For instance, certain phospholipid signaling modifiers are known to indirectly influence RUFY4 function by altering the lipid composition of cellular membranes, thereby affecting vesicular formation and trafficking that RUFY4 is known to participate in. Additionally, small molecules that modulate the activity of kinases involved in the autophagy pathway can indirectly enhance the activity of RUFY4 by shifting the cellular equilibrium towards processes that require RUFY4's involvement. While not interacting with RUFY4 directly, these compounds exert their effect by orchestrating a cellular environment conducive to the protein's optimal activity, thereby ensuring that the protein's role in autophagy and endosomal dynamics is carried out more efficiently.

The complexity of the signaling networks in which RUFY4 is involved implies that the activators can exert their influence through a myriad of pathways, often with a level of specificity that ensures the selective enhancement of RUFY4's activity. For example, modulators of mTOR signaling, a pathway that intersects with autophagy, can lead to a context where RUFY4 activity is amplified due to the heightened demand for autophagic flux. Similarly, compounds that affect the dynamics of actin cytoskeleton can indirectly impact RUFY4 by altering the cytoskeletal framework, which is essential for the proper localization and function of RUFY4 in vesicular trafficking. These activators, through their precise and targeted actions, facilitate the intrinsic activity of RUFY4, enhancing its role without altering its expression level or directly modifying its structure. In doing so, they provide a fundamental support system that amplifies the natural processes in which RUFY4 is a critical component, highlighting the intricate interplay between chemical signaling and protein function within the cell.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin activates adenylyl cyclase, increasing intracellular cAMP levels. The elevation of cAMP can enhance RUFY4 activity through protein kinase A (PKA) signaling, which can phosphorylate substrates that interact with RUFY4, thus increasing its functional activity within the cell.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can modulate calcium-dependent protein kinases and phosphatases that may alter the phosphorylation state of RUFY4, indirectly enhancing its activity.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates protein kinase C (PKC), which can phosphorylate RUFY4 or associated proteins, leading to an enhancement of RUFY4's cellular functions.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol activates sirtuin 1 (SIRT1), which can deacetylate proteins and could indirectly enhance the activity of RUFY4 by modifying the acetylation state of proteins in the RUFY4 pathway or RUFY4 itself, thereby affecting its function.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine is a DNA methyltransferase inhibitor that can lead to the demethylation of genes and affect their expression. It could indirectly enhance the activity of RUFY4 by altering the expression levels of regulatory proteins involved in RUFY4's pathway.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

Sphingosine-1-phosphate activates sphingosine-1-phosphate receptors, which can lead to the activation of signaling pathways that indirectly enhance the functional activity of RUFY4 by modulating cellular processes in which RUFY4 is involved.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor which could shift signaling in favor of pathways that activate RUFY4, thereby enhancing its activity.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is an MEK inhibitor that could lead to the activation of signaling pathways involving RUFY4 by inhibiting competing pathways, thus enhancing RUFY4 activity.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187 is another calcium ionophore that increases intracellular calcium, potentially enhancing the activity of RUFY4 through calcium-dependent signaling pathways.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which can lead to the activation of autophagy pathways. Since RUFY4 is known to be involved in autophagic processes, inhibition of mTOR could enhance the activity of RUFY4 through these pathways.